The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Malaria Vaccines Global Market Report 2024, the malaria vaccines market is expected to show significant growth in the forecast period.

The malaria vaccines market has witnessed exponential growth in recent years and is poised for significant expansion in the near future. This blog explores the market’s current trajectory, growth drivers, key players, and future trends shaping the industry.

Market Growth Trends

Historic Growth

• 2023 Market Size: $3.48 billion
• 2024 Market Size: $4.7 billion
• CAGR: 35.2%
• Drivers:
  • High malaria burden
  • Global health initiatives
  • Funding and grants
  • Malaria control programs
  • Government support and regulatory frameworks

Forecast Growth

• 2028 Market Size: $15.32 billion
• CAGR: 34.3%
• Drivers:
  • Global elimination goals
  • Expanded access programs
  • Increasing vaccine coverage
  • Global vaccine alliances
  • Climate change impact

View More On The Malaria Vaccines Market Report 2024 – https://www.thebusinessresearchcompany.com/report/malaria-vaccines-global-market-report

Key Market Drivers

Rise in Mosquito-Related Diseases

• Impact on Market:
  • Prevention and reduction of mosquito-borne diseases
  • Focus on RTS, S/AS01 (RTS, S) vaccine
• Statistics:
  • WHO Report (November 2023): Estimated 249 million malaria cases globally in 2022

Major Industry Players

Notable Companies

• Pfizer Inc.
• Novartis AG
• Sanofi SA
• GlaxoSmithKline Plc.
• Takeda Pharmaceutical Co Ltd.

Innovations and Strategies

Combatting Mosquito-Borne Diseases

• Technological Innovations:
  • Development of pediatric vaccines
  • Emphasis on Plasmodium falciparum
• Example:
  • Children’s Malaria Vaccine (November 2022): Launched in Malawi, Ghana, and Kenya

Strategic Moves

• Acquisition:
  • GlaxoSmithKline’s Acquisition of Affinivax Inc. (August 2022): Enhancing vaccine technology and market presence

Market Segmentation

By Agent

• Plasmodium Falciparum
• Plasmodium Vivax
• Anopheles Species

By Vaccine Type

• Pre-Erythrocytic
• Erythrocytic
• Multi-antigen
• Other Vaccines

By Route of Administration

• Intramuscular
• Subcutaneous
• Intradermal
• Other Routes

By Distribution Channel

• Public
• Private

Regional Insights

North America

• 2023: Largest market region

Asia-Pacific

• Forecast Period: Expected fastest-growing region

Conclusion

The malaria vaccines market is at a pivotal point with rapid growth anticipated in the coming years. Driven by technological advancements, strategic acquisitions, and global health initiatives, this market is crucial in combating mosquito-borne diseases worldwide. As innovations continue and global efforts intensify, the outlook for malaria prevention and treatment through vaccines remains promising.

Request A Sample Of The Global Malaria Vaccines Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=13698&type=smp